Latest round

Series B

Last raised

Jun 2011

Total raised

$19M

Investors

8

About PharmaEste

Founded in 2003 and is based in Italy, PharmaEste is a biopharmaceutical company, focuses on the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases.

Who invested in PharmaEste

8 investors across 3 rounds

See all investors in PharmaEste

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 1, 2011

    Amount

    $6.9M

    Investors

    Locked

  2. Series B

    Oct 2, 2008

    Amount

    $8.4M

    Investors

    Locked

  3. Series A

    Jan 1, 2007

    Amount

    $3.2M

    Investors

    Locked

Questions about PharmaEste

Who invested in PharmaEste?

PharmaEste has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PharmaEste raised?

PharmaEste has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did PharmaEste last raise money?

PharmaEste's most recent round on record is a Series B, in Jun 2011.

What does PharmaEste do?

Founded in 2003 and is based in Italy, PharmaEste is a biopharmaceutical company, focuses on the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases.

Where is PharmaEste headquartered?

PharmaEste is headquartered in Italy.

Which VCs invest in companies like PharmaEste?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at PharmaEste's stage. Their profiles are linked below.

Raising like PharmaEste? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.